Global Asthma Spacers Market 2019-2023 | Evolving Opportunities with ALLERGAN & Cipla | Technavio

November 13, 2019 Off By BusinessWire

LONDON–(BUSINESS WIRE)–#ALLERGAN–The global asthma spacers market size is poised to grow by USD 297.72 million during 2019-2023, according to a new report by Technavio, progressing at a CAGR of over 4% during the forecast period. Request Free Sample Pages

Read the 108-page research report with TOC on “Asthma Spacers Market Analysis Report by distribution channel (hospitals and retail pharmacies, and online stores) and geography (Americas, APAC, and EMEA) 2019-2023”.

The market is driven by the growing demand for respiratory care. Also, the increase in online retail is anticipated to further boost the growth of the asthma spacers market.

The growing demand for respiratory care is expected to drive the growth of the global asthma spacers market. Allergy, pollution, and smoking can result in several respiratory diseases such as obstructive airway diseases like asthma, COPD, and cystic fibrosis. Though COPD is not curable, medical and physical treatments are available to relieve symptoms. Aerosol therapy helps in relieving symptoms by enabling drug delivery directly into the lower airways for either topical or systemic effect. Healthcare practitioners and pharmacists recommend asthma spacers to patients taking inhaler therapy for uncontrolled asthma and COPD as these devices improve hand-breath coordination while reducing the side effects of inhaled medication.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Asthma Spacers Companies:


ALLERGAN has business operations under three segments, namely US specialized therapeutics, US general medicine, and international. The company’s key offerings include AeroChamber Plus Flow Vu Anti-Static VHC, which helps patients inhale the medication accurately.


Cipla develops, manufactures, sells, and distributes generic and branded generic medicines as well as active pharmaceutical ingredients (API). The company’s key offerings in the asthma spacers market include Zerostat VT Spacer. This product contains a transparent, non-static small-volume chamber with a flow-gate valve that helps in maximizing lung deposition.

Koninklijke Philips

Koninklijke Philips operates its business through various segments, including personal health, diagnosis & treatment, connected care & health informatics, and healthtech other. The company offers OptiChamber Diamond Spacer and holding chamber, which is designed to enhance medication delivery and compliance for patients of all ages, at home or in the hospital.


Headquartered in India, LUPIN is one of the growing global pharmaceutical companies in the world. The company offers InspiraChamber with SootherMask and InspiraMask, which combines three options to enhance the delivery of aerosol therapy.

Medical Developments International

Medical Developments International provides pharmaceutical drugs in regions such as Australia and the UK and some sales in New Zealand, Eastern Europe, the Middle East, and South Africa. The company’s key offerings include Anti-Static Compact Space Chamber Plus with Cross Valve Technology, and Space Chamber with 2 Valve Technology.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Asthma Spacers Distribution Channel Outlook (Revenue, USD Million, 2019-2023)

  • Hospital and retail pharmacies
  • Online stores

Asthma Spacers Regional Outlook (Revenue, USD Million, 2019-2023)

  • Americas
  • APAC
  • EMEA

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Health Care are:

Nebulization Masks Market – Nebulization Masks Market by product (reusable nebulization masks, and disposable nebulization masks) and geography (Americas, APAC, and EMEA).

Digital Dose Inhalers Market – Digital Dose Inhalers Market by product (metered dose and soft mist inhalers and dry powder inhalers) and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at [email protected].


Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200